| Kevin J Clayton, DO | |
|
1200 Sixth St, Suite 200, Traverse City, MI 49684-2369 | |
| (231) 935-5800 | |
| (231) 935-5799 |
| Full Name | Kevin J Clayton |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 1200 Sixth St, Traverse City, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528053188 | NPI | - | NPPES |
| 2995924 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 5101010007 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kevin J Clayton, DO 2891 Momentum Place, Chicago, IL 60689-5328 Ph: (231) 935-5800 | Kevin J Clayton, DO 1200 Sixth St, Suite 200, Traverse City, MI 49684-2369 Ph: (231) 935-5800 |
News Archive
In a study that included nearly 24,000 participants, those who experienced a stroke had an acute decline in cognitive function and also accelerated and persistent cognitive decline over 6 years, according to an article in the July 7 issue of JAMA.
Five minutes in a scanner can reveal how far a child's brain has come along the path from childhood to maturity and potentially shed light on a range of psychological and developmental disorders, scientists at Washington University School of Medicine in St. Louis have shown.Researchers assert this week in Science that their study proves brain imaging data can offer more extensive help in tracking aberrant brain development.
Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases, today announced it has achieved 100% specificity (no reproducible false positive results) upon testing 19,000 blood donations for variant Creutzfeldt-Jakob Disease ("vCJD") with the EP-vCJD(TM) Blood Screening Assay at l'Etablissement Français du Sang de Pyrénées Méditerrannée ("EFS-PM") in Montpellier, France.
A pioneering cancer treatment that causes minimal damage to surrounding cells will soon be available in the UK for global cancer patients to access.
› Verified 2 days ago
John P Milliken, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 224 Circle Dr, Traverse City, MI 49684 Phone: 231-935-0525 Fax: 231-935-0529 | |
Dr. David R Hendricks, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 153 1/2 E Front St, Traverse City, MI 49684 Phone: 231-941-6670 Fax: 231-941-6675 | |
Dr. Jill Elizabeth Vollbrecht, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5015 N Royal Dr, Traverse City, MI 49684 Phone: 231-935-0850 Fax: 231-935-0850 | |
Dr. Katrina Marie Lawrence-wolff, DO Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 3537 W Front St Ste A, Traverse City, MI 49684 Phone: 231-935-8330 Fax: 231-935-3437 | |
Steven M. Lamie, M. D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3537 W Front St, Suite I, Traverse City, MI 49684 Phone: 231-935-8950 Fax: 231-935-8868 | |
Anne M Hepner, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 Sixth St, Suite 200, Traverse City, MI 49684 Phone: 231-935-5800 Fax: 231-935-5799 | |
Mark V Galan, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4100 Park Forest Dr, Suite 208, Traverse City, MI 49684 Phone: 231-935-5710 Fax: 231-935-9045 |